1.
Cell
; 171(5): 982-986, 2017 Nov 16.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29149611
RESUMEN
The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.